Completion of acquisition of 64.26% stake in Kronox Lab Sciences
The company has completed its acquisition of 2,38,44,000 equity shares of Kronox Lab Sciences Limited, being 64.26% of Kronox's total paid-up equity share capital, on September 29, 2026.
- Shares Acquired
- 2,38,44,000 equity shares
- Stake Percentage
- 64.26% of Kronox's total paid-up equity share capital
- Completion Date
- September 29, 2026
- Agreement Date
- August 20, 2026
What was announced
Indo Borax & Chemicals Limited (the Purchaser) has informed the stock exchanges that its acquisition of shares in Kronox Lab Sciences Limited (the Target Company) has been completed on September 29, 2026.
- Shares acquired: 2,38,44,000 equity shares
- Stake acquired: 64.26% of the total paid-up equity share capital of Kronox Lab Sciences Limited
How the deal came about
The transaction follows a share purchase agreement dated August 20, 2026 between the Sellers — Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani and Mr. Jogindersingh Gianchand Jaswal — Indo Borax & Chemicals Limited as Purchaser, and Zenrock Chemicals Private Limited. The execution of that agreement had been disclosed earlier as the Original Intimation.
The company states that, apart from the completion now reported, there is no change in the other details that were disclosed in the Original Intimation.
Why it matters for investors
Acquiring a majority stake of 64.26% gives the company controlling ownership in Kronox Lab Sciences Limited, a listed company in the chemicals space. Moving from an agreement stage to completion means the transaction has closed and the shares have changed hands.
The update was signed by Sunil Malhotra, Director, at Mumbai on September 29, 2026.
Also from Indo Borax & Chemicals
Indo Borax completes acquisition of 64.26% stake in Kronox Lab Sciences, appoints Suresh Kalra as MD & CEO
1 Oct 2026
Rs. 225 crore funding availed from lending institution to finance Kronox Lab Sciences share acquisition
24 Sep 2026
More numbers
- Equity shares acquired in Kronox Lab Sciences2,38,44,000 equity shares
- Stake acquired in paid-up equity capital64.26%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.